Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Connect Twitter with Market Wire News

ALNY - Alnylam Pharmaceuticals Stock Trading


home / stock / alny

ALNY ALNY Quote ALNY Short ALNY News ALNY Articles ALNY Message Board

About | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

Not available

Quote | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

Last:$169.175
Change Percent: 0.55%
Open:$167.93
Close:$168.25
High:$169.765
Low:$166.02
Volume:161,081
Last Trade Date Time:12/01/2023 03:00:00 am

News | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

  • Arrowhead Pharmaceuticals: Balance Sheet Concern Needs To Be Addressed

    2023-12-01 09:00:08 ET Summary Shares of Arrowhead Pharmaceuticals dropped this week after the company reported fiscal Q3 2023 results. Balance sheet concerns are weighing on the stock, and this is an urgent issue the company needs to address, and it has several options at its dis...

    • December 01, 2023 09:00:08 am
    • |
    • SeekingAlpha
    • |
      • ALNY Stock
      • ALNY Quote
      • ALNY Short
      • ALNY News
      • ALNY Articles
      • ALNY Message Board
  • Alnylam Ranks #1 on Boston Globe's Top Places to Work List for 2023

    – Recognition Marks Alnylam’s Ninth Year in a Row on this Prestigious List, and the Third Consecutive Year Ranking #1 – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced its first-place ranking in Boston Globe’...

    • November 30, 2023 08:00:00 am
    • |
    • Business Wire
    • |
      • ALNY Stock
      • ALNY Quote
      • ALNY Short
      • ALNY News
      • ALNY Articles
      • ALNY Message Board

Message Board Posts | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

Subject By Source When
whytestocks: $ALNY News Article - Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study whytestocks investorshangout 09/13/2022 12:25:48 PM
whytestocks: $ALNY News Article - Alnylam Announces Pricing of Offering of $900 Million Convertible whytestocks investorshangout 09/13/2022 12:20:47 PM
whytestocks: $ALNY News Article - Alnylam Presents Positive Results from the APOLLO-B Phase 3 Study whytestocks investorshangout 09/08/2022 4:15:54 PM
whytestocks: $ALNY News Article - Alnylam to Webcast Presentation at Morgan Stanley 20th Annual Glob whytestocks investorshangout 09/06/2022 12:20:48 PM
whytestocks: $ALNY News Article - Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Bo whytestocks investorshangout 08/24/2022 8:06:00 PM
Stock Information

Get ALNY Alerts

News, Short Squeeze, Breakout and More Instantly...

Alnylam Pharmaceuticals Inc. Company Name:

ALNY Stock Symbol:

NASDAQ Market:

Alnylam Pharmaceuticals Inc. Website:

Alnylam Pharmaceuticals Inc. Logo

Ad

Connect Twitter with Market Wire News
RECENT ALNY NEWS
  • ALNY - Alnylam Ranks #1 on Boston Globe's Top Places to Work List for 2023

    – Recognition Marks Alnylam’s Ninth Year in a Row on this Prestigious List, and the Third Consecutive Year Ranking #1 – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced its first-place ranking in Boston Globe’...

  • ALNY - Alnylam Pharmaceuticals Inc. $ALNY Trading Signals

    2023-11-21 00:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

  • ALNY - Alnylam Presents Positive Results from the KARDIA-1 Phase 2 Dose-Ranging Study of Zilebesiran, an Investigational RNAi Therapeutic in Development for the Treatment of Hypertension in Patients at High Cardiovascular Risk

    – Zilebesiran Met Primary Endpoint Demonstrating Up to 16.7 mmHg Placebo-Adjusted Reduction of 24-Hour Mean Systolic Blood Pressure at Three Months of Treatment – – Study Met Key Secondary Endpoints Showing Consistent and Sustained Reductions of Systolic Blood Pressur...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.



Market Wire News App

Sign up for the Market Wire News App now!

The Market Wire news app is set to launch soon, be one of the first to try it out before it's in the store.



Be alerted of any news about your stocks and see what other stocks are trending.

Market Wire News App

Sign up for the Market Wire News App now!

The Market Wire news app is set to launch soon, be one of the first to try it out before it's in the store.



Be alerted of any news about your stocks and see what other stocks are trending.

Get ALNY Alerts

Get ALNY Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| Google News

| X

| Facebook

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2023 Market Wire News